CRISPR-focused Excision BioTherapeutics Strengthens Board of Directors Appointing Veteran Pharmaceutical Executive Bill Carson, M.D.
December 03, 2019 12:30 ET
|
Excision BioTherapeutics
Oakland, CA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc., a biotechnology company developing CRISPR-based therapies to cure viral infectious diseases, today announced that...
Animal Model Market to hit $24 billion by 2025: Global Market Insights, Inc.
November 25, 2019 06:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Global Animal model market is projected to cross USD 24 billion by 2025, according to a new research report by Global Market Insights,...
Excision BioTherapeutics Presents Data to Support HIV Cure Using CRISPR Gene Editing Technology
November 21, 2019 12:00 ET
|
Excision BioTherapeutics
Oakland, CA, Nov. 21, 2019 (GLOBE NEWSWIRE) -- On November 20 at the 6th Annual Personalized Nanomedicine Symposium, researchers working with Excision BioTherapeutics, a gene therapy company...
CRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cure
November 18, 2019 12:00 ET
|
Excision BioTherapeutics
Oakland, CA, Nov. 18, 2019 (GLOBE NEWSWIRE) -- At the 2019 International Symposium on Neurovirology, Excision BioTherapeutics, a gene therapy company focusing on curing viral infectious diseases,...
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the 7th Plant Genomics & Gene Editing Congress
November 05, 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Arbor Biotechnologies Announces Issuance of U.S. Patent for CRISPR-Cas13d
September 25, 2019 09:16 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company, today announced that the United States Patent and Trademark Office (USPTO) has...
Intégration de la technologie CRISPR-cas9 pour accélérer la découverte et l’optimisation d’antibiotiques innovants
September 23, 2019 12:30 ET
|
Deinove
Intégration de la technologie CRISPR-cas9 pour accélérer la découverte et l’optimisation d’antibiotiques innovants DEINOVE renforce son expertise dans l’ingénierie génétique de microorganismes rares...
Integration of CRISPR-case9 technology to accelerate the discovery of innovative antibiotics
September 23, 2019 12:30 ET
|
Deinove
Integration of CRISPR-case9 technology to accelerate the discovery of innovative antibiotics DEINOVE strengthens its expertise in the genetic engineering of rare and varied microorganisms to...
Arbor Biotechnologies Selected For MIT STEX25
July 09, 2019 11:52 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., July 09, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor), an early-stage biodiscovery company, announced today that it has been selected for STEX25, an MIT Startup Exchange...
HIV Eliminated from the Genomes of Living Animals; Excision BioTherapeutics Advancing the Innovation to Clinical Development
July 02, 2019 11:16 ET
|
Excision BioTherapeutics
Philadelphia, July 02, 2019 (GLOBE NEWSWIRE) -- Researchers at the Lewis Katz School of Medicine at Temple University and the University of Nebraska Medical Center (UNMC) have for the first time in...